Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-14 5:01 pm Purchase | 2023-12-31 | 13G | ASCENDIS PHARMA A/S SPONSORED ASND | RA Capital Management, L.P. | 10,107,400 17.500% | 140,228 (+1.41%) | Filing History |
| 2024-02-14 5:01 pm Sale | 2023-12-31 | 13G | AVIDITY BIOSCIENCES INC RNAM | RA Capital Management, L.P. | 2,454,533 3.300% | -3,000,000 (-55.00%) | Filing History |
| 2024-02-14 5:01 pm Purchase | 2023-12-31 | 13G | DAY ONE BIOPHARMACEUTICALS INC DAWN | RA Capital Management, L.P. | 7,809,852 9.000% | 769,230 (+10.93%) | Filing History |
| 2024-02-14 5:01 pm Purchase | 2023-12-31 | 13G | FULCRUM THERAPEUTICS INC FULC | RA Capital Management, L.P. | 11,609,704 18.800% | 1,923,076 (+19.85%) | Filing History |
| 2024-02-14 5:01 pm Purchase | 2023-12-31 | 13G | GERON CORP GERN | RA Capital Management, L.P. | 55,145,502 9.990% | 6,722,291 (+13.88%) | Filing History |
| 2024-02-14 5:01 pm Purchase | 2023-12-31 | 13G | GH RESH PLC SHS GHRS | RA Capital Management, L.P. | 5,587,333 10.700% | 26,215 (+0.47%) | Filing History |
| 2024-02-14 5:01 pm Sale | 2023-12-31 | 13G | GRACELL BIOTECHNOLOGIES INC SP GRCL | RA Capital Management, L.P. | 48,600,221 9.990% | -79 (-0.00%) | Filing History |
| 2024-02-14 5:01 pm Purchase | 2023-12-31 | 13G | INHIBRX INC INBX | RA Capital Management, L.P. | 4,724,352 9.990% | 870,485 (+22.59%) | Filing History |
| 2024-02-14 5:01 pm Purchase | 2023-12-31 | 13G | MACROGENICS INC MGNX | RA Capital Management, L.P. | 4,053,077 6.500% | 288,206 (+7.66%) | Filing History |
| 2024-02-14 5:01 pm Purchase | 2023-12-31 | 13G | RXSIGHT INC RXST | RA Capital Management, L.P. | 3,404,285 9.500% | 351,489 (+11.51%) | Filing History |
| 2024-02-14 5:01 pm Sale | 2023-12-31 | 13G | TAYSHA GENE THERAPIES INC TSHA | RA Capital Management, L.P. | 18,670,089 9.990% | -20,779 (-0.11%) | Filing History |
| 2024-02-14 5:01 pm Purchase | 2023-12-31 | 13G | TENAYA THERAPEUTICS INC TNYA | RA Capital Management, L.P. | 6,948,236 9.990% | 519,753 (+8.09%) | Filing History |
| 2024-02-14 5:01 pm Purchase | 2023-12-31 | 13G | VAXCYTE INC PCVX | RA Capital Management, L.P. | 9,685,079 9.990% | 1,531,520 (+18.78%) | Filing History |
| 2024-02-14 5:01 pm Sale | 2023-12-31 | 13G | VERONA PHARMA PLC SPONSORED AD VRNA | RA Capital Management, L.P. | 7,503,976 9.990% | -188,014 (-2.44%) | Filing History |
| 2024-02-14 5:01 pm Purchase | 2023-12-31 | 13G | HARPOON THERAPEUTICS INC N HARP | RA Capital Management, L.P. | 1,712,792 9.990% | 11,222 (+0.66%) | Filing History |
| 2024-02-14 5:01 pm Sale | 2023-12-31 | 13G | CELCUITY INC CELC | RA Capital Management, L.P. | 1,286,960 5.000% | -962,461 (-42.79%) | Filing History |
| 2024-02-14 5:01 pm Purchase | 2023-12-31 | 13G | APOGEE THERAPEUTICS INC APGE | RA Capital Management, L.P. | 1,977,901 5.300% | 1,977,901 (New Position) | Filing History |
| 2024-02-14 5:01 pm Sale | 2023-12-31 | 13G | RHYTHM PHARMACEUTICALS INC RYTM | RA Capital Management, L.P. | 5,330,412 9.000% | -185,655 (-3.37%) | Filing History |
| 2024-02-14 5:01 pm Purchase | 2023-12-31 | 13G | UROGEN PHARMA LTD URGN | RA Capital Management, L.P. | 3,083,558 9.990% | 8 (+0.00%) | Filing History |
| 2024-02-14 5:01 pm Sale | 2024-02-14 | 13G | NEWAMSTERDAM PHARMA CO NV SHS NAMS | RA Capital Management, L.P. | 8,197,333 9.900% | -1,136,000 (-12.17%) | Filing History |